Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.

@article{Jordan2013PatternsOC,
  title={Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.},
  author={Susan J Jordan and Christopher B Steer and Anna deFazio and Monique Quinn and Andreas Obermair and Michael Friedlander and Jenny K.R. Francis and Seamus O'Brien and G. Goss and David Wyld and Australian Ovarian Cancer Study Group and Penelope M. Webb},
  journal={Gynecologic oncology},
  year={2013},
  volume={129 2},
  pages={
          310-7
        }
}
OBJECTIVE Ovarian cancer five-year survival is poor at <40%. In the absence of effective screening or new treatments, ensuring all women receive optimal treatment is one avenue to improve survival. There is little population-based information regarding the primary chemotherapy treatment that women with epithelial ovarian cancer receive. This information is essential to identify potential gaps in care. METHODS Cancer registries identified all women diagnosed with invasive epithelial ovarian… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study

  • European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation
  • 2017
VIEW 3 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2010
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2011
VIEW 3 EXCERPTS